Skip to main content
H.R. 7410 117th Congress House

American Made Medicine Act

Official title: To amend the Internal Revenue Code of 1986 to provide for credits against tax for domestic medical and drug manufacturing and advanced medical manufacturing equipment.

Introduced: April 14, 2022 See on congress.gov
Taxation Advanced technology and technological innovationsAir qualityBusiness investment and capitalHealth technology, devices, supplies
More subjectsShow fewer subjects
Income tax creditsIncome tax ratesIndustrial policy and productivityInflation and pricesManufacturingPrescription drugsSales and excise taxesTrade restrictionsU.S. and foreign investmentsWages and earningsWater quality
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 5, 2022
Referred to the House Committee on Ways and Means.
Apr 5, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 5, 2022

Referred to the House Committee on Ways and Means.

 Plain-English summary Congressional Research Service

American Made Medicine Act

This bill allows employers tax credits for domestic medical and drug manufacturing expenses and for advanced medical manufacturing equipment. It also provides a tax credit for a percentage of the basis of qualifying medical manufacturing EPA compliance property placed in service before January 1, 2029, or during calendar year 2030.

The bill defines qualifying medical manufacturing EPA compliance property as depreciable property used by a taxpayer in the trade or business of manufacturing a drug, device, biological product, or active pharmaceutical ingredient or covered countermeasure (e.g., a qualified pandemic or epidemic product, security countermeasure, or respiratory protective device). The property must meet emissions limits under the Clean Air Act or wastewater standards under the Clean Water Act.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Lobbying activity 1

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • FIERCE GOVERNMENT RELATIONS
    for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA) · District of Columbia · 2nd Quarter 2026 (Apr 1 - June 30)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 4
All 4 Republican 3
R
LaHood, Darin
Illinois · Jul 21, 2022
 R
Buchanan, Vern
Florida · Apr 14, 2022
 R
Kelly, Mike
Pennsylvania · Apr 14, 2022
Ferguson, A.
· Apr 5, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 7410: American Made Medicine Act. 117th Congress. Open America. https://openamerica.io/bill/117-HR-7410/
MLA
"H.R. 7410: American Made Medicine Act." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-7410/.
Bluebook (legal)
H.R. 7410, 117th Cong. (2026), https://openamerica.io/bill/117-HR-7410/.
Markdown link
[H.R. 7410: American Made Medicine Act](https://openamerica.io/bill/117-HR-7410/)
Report a problem